Active Ingredient: EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
Proprietary Name: COMPLERA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG;EQ 25MG BASE;300MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N202123
Product Number: 001
Approval Date: Aug 10, 2011
Applicant Holder Full Name: GILEAD SCIENCES INC
Marketing Status:
Prescription
Patent and Exclusivity Information
